Skip to main content

Research News

  • A new research claims, Autism Spectrum Disorder More Frequently Observed in Boys Than in Girls. The study was published in the journal Molecular Autism.

    Autism spectrum disorder (ASD) is a condition that affects social interaction, communication, interests and behaviour. The study followed a large sample of boys and girls at high-risk for the disorder and other children at low risk beginning before 18 months of age. One in four high-risk boys were identified with the disorder at three years, compared to one in 10 high-risk girls.

  • Finnish researchers have developed the world's first paper-based drug test that enables a rapid analysis of whether a compound, such as morphine, is present in a given sample. Researchers from VTT Technical Research Centre of Finland used antibodies - produced by methods of molecular biology - as morphine sensing molecules to create the drug test printed on paper.

  • The immune system release specific antibodies when it encounters a virus. It can continue to produce those antibodies decades after an infection subsides. VirScan test detects those antibodies and uses them as a window in time to create a blueprint of nearly every virus an individual has encountered.  The test, known as VirScan, works by screening the blood for antibodies against any of the 206 species of viruses known to infect humans.Researchers at Columbia University found a DNA-based blood test which can determine a person's entire viral history. This new test can lead to early detection of hepatitis C, certain autoimmune diseases and cancers. This new innovation test only for a single suspected virus. The study appears in Science.

  • A star-shaped brain cell called an astrocyte appears to help keep blood pressure and blood flow inside the brain on a healthy, report scientists. The finger-like appendages of astrocytes, called end-feet, quite literally wrap around the countless, fragile blood vessels in the brain, constantly monitoring what is going on inside and around them.  The paper appeared in The Journal of Neuroscience.

  • In a breakthrough, scientists have identified a tiny molecule that forces the HIV virus to open up and expose its vulnerable parts, allowing the immune system to kill the infected body cells. The finding opens a new path in the fight against HIV and could ultimately lead to the design of a vaccine to prevent transmission of the virus, researchers said.

  • A  study revealed that Drinking sugar-sweetened beverages daily may increase the risk of Non-alcoholic fatty liver disease (NAFLD).  Non-alcoholic fatty liver disease (NAFLD) is the build up of extra fat in liver cells that is not caused by alcohol. It is normal for the liver to contain some fat. However, if more than 5% - 10% percent of the liver’s weight is fat, then it is called a fatty liver (steatosis).Sugar-sweetened beverages are a major dietary source of fructose, the sugar which is suspected of increasing risk of NAFLD because of how our bodies process it. The study appeared in the Journal of Hepatology.

  • A new study said that Botulinum toxin, commonly known as Botox could offer an effective new treatment for two forms of neuropathy, pain caused by different types of nerve injury. The study appeared in Anesthesia & Analgesia.

  • Scientists found the drug was effective in two different strains of mice and three different strains of flu believe the drug could be effective in animals other than mice, including humans. Scientists in Canada  developed a new drug that are effective against flu virus.People who die from the flu actually die from respiratory failure, when the lung's tiny blood vessels start leaking fluid into the lung's air sacs. Instead of targeting the virus that causes flu, the new drug can prevent the blood vessels from leaking fluid into the lung's air sacs.

  • Hepatitis B virus is a leading cause of liver disease. Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. It is a major global health problem.  A new study has found that an antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV). The study is published in Clinical Gastroenterology and Hepatology.

    [adsense:336x280:8701650588]

Subscribe to Research News